Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?
Frontiers In Oncology
Capogiri, Monica M; De Micheli, Andrea J AJ; Lassaletta, Alvaro A; Muñoz, Denise P DP; Coppé, Jean-Philippe JP; Mueller, Sabine S; Guerreiro Stucklin, Ana S AS
Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Schreck, Karisa C KC; Morin, Andrew A; Zhao, Guisheng G; Allen, Amy N AN; Flannery, Patrick P; Glantz, Michael M; Green, Adam L AL; Jones, Chris C; Jones, Kenneth L KL; Kilburn, Lindsay B LB; Nazemi, Kellie J KJ; Samuel, David D; Sanford, Bridget B; Solomon, David A DA; Wang, Jiawan J; Pratilas, Christine A CA; Nicolaides, Theodore T; Mulcahy Levy, Jean M JM
A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAFV600E-Mutant Brain Tumor.
Cancer Discovery
Wang, Jiawan J; Yao, Zhan Z; Jonsson, Philip P; Allen, Amy N AN; Qin, Alice Can Ran ACR; Uddin, Sharmeen S; Dunkel, Ira J IJ; Petriccione, Mary M; Manova, Katia K; Haque, Sofia S; Rosenblum, Marc K MK; Pisapia, David J DJ; Rosen, Neal N; Taylor, Barry S BS; Pratilas, Christine A CA
Structure-based design of an organoruthenium phosphatidyl-inositol-3-kinase inhibitor reveals a switch governing lipid kinase potency and selectivity.
Acs Chemical Biology
Xie, Peng P; Williams, Douglas S DS; Atilla-Gokcumen, G Ekin GE; Milk, Leslie L; Xiao, Min M; Smalley, Keiran S M KS; Herlyn, Meenhard M; Meggers, Eric E; Marmorstein, Ronen R